email article
Here is a roundup of some of the best medical apps we loved and found useful during the COVID-19 pandemic over the past year in no particular order.
Happy downloading and stay safe!
The Brigham and Women s Hospital released a comprehensive app of all of their COVID-19 protocols. This app joins a growing list of guidelines and protocols from Johns Hopkins (via the Relief Central and Hopkins ABX Guide apps), WHO, Society of Critical Care Medicine (SCCM), National Institutes of Health (NIH), and others.
MyDirectives.com first launched its companion app for iOS in 2015. Their website and app can be used separately, but ideally, they should be used together. The website discusses the goals of create, update, and share. The app allows the user to digitally sign the plan; make a video of your wishes; use photos and videos to confirm your identity; share the Advance Care plan with others via email, text, and QR reader; and show on the iPhone lock screen!
Early research and clinical testing of new antibody cocktails have shown promising outcomes in slowing the progression and shortening the duration of COVID-19 for patients with mild to moderate symptoms, and preventing hospitalization.
But the early studies involve small numbers of patients and there is no long-term evidence about its safety and efficacy as clinical research is ongoing. The Infectious Diseases Society of America has come out against routine use of the therapies.
The availability of the new treatment comes as COVID-related hospitalizations in Pennsylvania have skyrocketed since Thanksgiving, exceeding numbers early in the pandemic.
Pennsylvania on Tuesday reported 6,151 adults were hospitalized statewide with COVID-19, including more than 1,200 in intensive care. Patients on ventilators jumped to 772 on Tuesday, 34 more than reported Monday.
Answers to Key Questions About Coronavirus Vaccine Kevin Loria
Consumer Reports has no financial relationship with advertisers on this site.
In a remarkably short period of time less than one year scientists managed to design, create, and test several potential vaccines for SARS-CoV-2, the virus that causes COVID-19.
On Dec. 11, the Food and Drug Administration issued the first emergency use authorization for a coronavirus vaccine, the one developed by Pfizer and BioNTech. On Dec. 18, the FDA issued a second emergency authorization, for a vaccine developed by Moderna, which is based on similar technology.
On Feb. 27, the FDA issued a third emergency use authorization, this time for a vaccine developed by Johnson & Johnson. This vaccine is based on a different technology from the other two authorized so far, and provides protection after just one shot. The others require two injections.
Many U.S. health experts underestimated the coronavirus until it was too late [Los Angeles Times]
A year ago, while Americans were finishing their holiday shopping and finalizing travel plans, doctors in Wuhan, China, were battling a mysterious outbreak of pneumonia with no known cause.
Chinese doctors began to fear they were witnessing the return of severe acute respiratory syndrome, or SARS, a coronavirus that emerged in China in late 2002 and spread to 8,000 people worldwide, killing almost 800.
The disease never gained a foothold in the U.S. and disappeared by 2004.
But SARS cast a long shadow that colored how many nations and U.S. scientists reacted to its far more dangerous cousin, the novel coronavirus that causes COVID-19.
Many US health experts underestimated the coronavirus … until it was too late mdjonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mdjonline.com Daily Mail and Mail on Sunday newspapers.